Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Lymphocyte Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00006298
What this trial is testing

Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 125
Not applicableStudy completedNCT00002061
What this trial is testing

A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy

Who this might be right for
Lymphatic DiseaseHIV Infections
Newport Pharmaceuticals International
Testing effectiveness (Phase 2)Study completedNCT01426828
What this trial is testing

Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant

Who this might be right for
Multiple Myeloma
University of Pennsylvania 40
Not applicableStudy completedNCT00956475
What this trial is testing

Quality of Life in Younger Leukemia and Lymphoma Survivors

Who this might be right for
Anxiety DisorderCancer SurvivorFatigue+7 more
Case Comprehensive Cancer Center 48
Early research (Phase 1)Study completedNCT00017628
What this trial is testing

Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Northwestern Memorial Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT02763254
What this trial is testing

Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas

Who this might be right for
Hodgkin LymphomaLymphoma, Large B-Cell, DiffusePost-transplant Lymphoproliferative Disorder
Cell Medica Ltd 1
Testing effectiveness (Phase 2)Ended earlyNCT01805037
What this trial is testing

Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+114 more
Northwestern University 20
Not applicableUnknownNCT05362812
What this trial is testing

Prediction of Lupus Renal Flares Study

Who this might be right for
Systemic Lupus Erythematosus
Charite University, Berlin, Germany 120
Not applicableNo Longer AvailableNCT03594162
What this trial is testing

Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch

Who this might be right for
Acute Lymphoblastic LeukemiaImmune System DiseasesImmunoproliferative Disorders
UNC Lineberger Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT03790072
What this trial is testing

Ex-vivo Expanded γδ T-lymphocytes (OmnImmune®) in Patients With Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukemia
TC Biopharm 10
Testing effectiveness (Phase 2)Looking for participantsNCT06532812
What this trial is testing

TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer

Who this might be right for
Breast CancerBreast CarcinomaBreast Cancer Metastatic+1 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT02200445
What this trial is testing

Low Dose IL-2 for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Scott B. Snapper, MD PHD 26
Not applicableStudy completedNCT02695966
What this trial is testing

EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cambridge University Hospitals NHS Foundation Trust 20
Not applicableStudy completedNCT00993694
What this trial is testing

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Vanderbilt University 41
Early research (Phase 1)Study completedNCT02689453
What this trial is testing

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

Who this might be right for
T-Cell Lymphoma RelapsedAdult T-Cell Leukemia (ATL)Peripheral T-Cell Lymphoma (PTCL)+2 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Looking for participantsNCT07450391
What this trial is testing

EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders

Who this might be right for
Epstein-Barr Virus-Associated Lymphoproliferative DisordersEBV-Positive Lymphoma
Daihong Liu 18
Not applicableNot Yet RecruitingNCT07331701
What this trial is testing

Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study

Who this might be right for
Lung NeoplasmsTumor Immune Microenvironment
Seoul National University Hospital 60
Large-scale testing (Phase 3)UnknownNCT02231281
What this trial is testing

Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults

Who this might be right for
Acute HIV Infection
Yongtao Sun, MD, PhD 65
Not applicableUnknownNCT06169111
What this trial is testing

REGulatory T Cells in Autism Induced by Maternal Immune Activation

Who this might be right for
Autism Spectrum Disorder
Assistance Publique - Hôpitaux de Paris 70
Not applicableEnded earlyNCT00000875
What this trial is testing

Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 16
Next Page